Yarlagadda S. Babu, Chief Discovery Officer at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 30,100 shares at $12.20 ($367K) on 2021-12-07, disclosed to the SEC on 2021-12-09.
Open-market sale of $367k BCRX by Chief Discovery Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BCRX | BUY | 2019-11-18 | $36K | — | Filing → |
| BCRX | SELL | 2016-08-29 | $244K | — | Filing → |
| BCRX | SELL | 2015-03-20 | $123K | — | Filing → |